Novartis (NVS) news

Kynexis: financing was led by new investor Novartis Venture Fund, with participation from existing investors Forbion, Ysios Capital, and others

Shanghai Fosun Pharmaceutical says unit signs framework cooperation agreement with Sandoz AG

Shanghai Fosun Pharmaceutical Group Co., Ltd. (600196.SH; 02196.HK) has announced a strategic collaboration with Sandoz AG, a subsidiary of Novartis, through a framework cooperation agreement. The partnership aims to enhance global drug development and commercialization efforts, leveraging Fosun…

PeptiDream to get milestone payment for Novartis clinical trial

PeptiDream Inc. has received a milestone payment following the initiation of a Phase 2 clinical trial by Novartis for a peptide-based therapeutic candidate. The trial, part of an expanded collaboration between the two companies, focuses on the development of macrocyclic peptides for targeted…

Dr. Reddy's Labs ends distribution pact with Novartis India

Dr. Reddy's Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL) for select products, including the Voveran range, Calcium range, and Methergine . Under the arrangement, Dr. Reddy's will assume exclusive rights to promote and distribute these…

Novartis India - to re-buy exclusivity and market access for products after DRL agreement termination

Novartis India has announced plans to re-establish exclusivity and market access for certain products following the termination of its sales and distribution agreement with Dr. Reddy’s Laboratories (DRL). The agreement, which involved key brands such as Voveran, the Calcium range, and Methergine,…